drugset / Trial / NCT02795351

Induction of Migraine Aura With Sildenafil

NCT02795351 ↗

Phase 0 Completed 16 enrolled Herlev Hospital
RandomizedCrossoverQuadruple-blindBasic science

Summary

In a double blind placebo-controlled cross-over study the effect of Sildenafil on aura and migraine headache induction is tested in patient with migraine with aura.

Timeline

Start
2015-06
Primary completion
2021-02
Completion
2021-08

Outcome

Met primary endpoint

paper Aura symptoms were induced in three patients (19%) after sildenafil and none after placebo (P < 0.001). PMID 35332812 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 100 mg Oral

Indications